Apex Healthcare Berhad Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Apex Healthcare Berhad Stock Forecast and Price Target
Apex Healthcare Berhad's most recent price target of RM2.64 for 2024 was provided by renowned analysts over the past few months, with an average prediction of RM2.64. If this prediction is correct, Apex Healthcare Berhad's stock could fall by -12 percent from its current trading price. The potential decrease for the stock is RM2.64 per share, with a possible range of RM2.40 to RM2.90. If you're not interested in AHEALTH stock, you may be interested in its competitors.
-12.00% Downside
Apex Healthcare Berhad Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Apex Healthcare Berhad's Price has decreased by 100.00%, going from RM2.10 to RM0.00. In the next year, analysts believe that Fair Value will reach RM3.42 – an increase of 100.00%. For the next seven years, experts predict that Apex Healthcare Berhad's Fair Value will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
DPHARMA Stock Forecast | Duopharma Biotech Berhad | Buy |
17
|
RM1.16 | Buy/Sell | RM1.48 | 28.45% |
KOTRA Stock Forecast | Kotra Industries Berhad | Outperform |
16
|
RM4.70 | Buy/Sell | RM5.79 | 14.89% |
YSPSAH Stock Forecast | Y.S.P. Southeast Asia Holding ... | - |
6
|
RM2.43 | Buy/Sell | RM3.00 | -100.00% |
NOVA Stock Forecast | Nova Wellness Group Berhad | Outperform |
16
|
RM0.52 | Buy/Sell | RM0.72 | 30.77% |
RHONEMA Stock Forecast | Rhone Ma Holdings Berhad | Hold |
0
|
RM0.66 | Buy/Sell | RM0.68 | 3.03% |
Apex Healthcare Berhad Revenue Forecast for 2023 - 2025 - 2030
Apex Healthcare Berhad's Revenue has grown In the last three years, rising from RM698.73M to RM936.17M – a growth of 33.98%. In the next year, analysts believe that Revenue will reach RM994.33M – an increase of 6.21%. For the next seven years, experts predict that Apex Healthcare Berhad's Revenue will grow at a rate of 6.92%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
SUNZEN Stock Forecast | Sunzen Biotech Berhad | - |
0
|
RM0.28 | Buy/Sell | RM0.00 | -100.00% |
BIOHLDG Stock Forecast | Bioalpha Holdings Berhad | - |
0
|
RM0.09 | Buy/Sell | RM0.24 | -100.00% |
PLABS Stock Forecast | PeterLabs Holdings Berhad | - |
12
|
RM0.20 | Buy/Sell | RM0.00 | -100.00% |
Apex Healthcare Berhad Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Apex Healthcare Berhad's Dividend per Share has decreased from RM0.05 to RM0.04 – a 20.00% drop. In the next year, analysts believe that Dividend per Share will reach RM0.06 – an increase of 50.00%. For the next seven years, the forecast is for Dividend per Share to grow by 59.23%.
Apex Healthcare Berhad EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Apex Healthcare Berhad's EBITDA has grown, moving from RM68.99M to RM90.05M – an increase of 30.53%. In the next year, analysts predict that EBITDA will jump to RM113.53M – up 26.07% from the current level. Looking ahead to seven years, experts forecast that EBITDA will grow by 34.31%.
Apex Healthcare Berhad EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Apex Healthcare Berhad's EBIT has seen an increase, rising from RM53.47M to RM72.89M. This represents a growth of 36.32%. Analysts predict that Apex Healthcare Berhad's EBIT will increase in the upcoming year, reaching RM91.90M. This would represent an increase of 26.08%. Over the next seven years, experts predict that Apex Healthcare Berhad's EBIT will grow at a rate of 55.23%.
Apex Healthcare Berhad EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Apex Healthcare Berhad's EPS has decreased by 100.00%, going from RM0.08 to RM0.00. In the next year, analysts believe that EPS will reach RM0.13 – an increase of 100.00%. For the next seven years, experts predict that Apex Healthcare Berhad's EPS will grow at a rate of 100.00%.